Stelara and Cholecystitis infective - a phase IV clinical study of FDA data

Summary:

Cholecystitis infective is reported as a side effect among people who take Stelara (ustekinumab), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Enbrel, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Cholecystitis infective when taking Stelara. It is created by eHealthMe based on reports of 95,658 people who have side effects when taking Stelara from the FDA, and is updated regularly.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.

What is Cholecystitis infective?

Cholecystitis infective (infection of gallbladder capable to infect other organs) is found to be associated with 392 drugs and 405 conditions by eHealthMe. Check the latest studies of Cholecystitis infective.

On Aug, 11, 2026

95,658 people reported to have side effects when taking Stelara.
Among them, 50 people (0.05%) have Cholecystitis infective.

Could Stelara cause Cholecystitis infective?

Among these 50 people:

How long have people been on Stelara when they have Cholecystitis infective? *

What is the gender of people who have Cholecystitis infective when taking Stelara? *

female: 40.82 %
male: 59.18 %

What is the age of people who have Cholecystitis infective when taking Stelara? *

What are other drugs people take besides Stelara? *

What are other side effects people have besides Cholecystitis infective? *

Cough: 12 people, 24.00%
Productive Cough: 10 people, 20.00%
Gallstones (stone formation by bile component): 10 people, 20.00%
Itching: 9 people, 18.00%
Rashes (redness): 9 people, 18.00%
Urinary Tract Infection: 8 people, 16.00%
Abdominal Pain: 4 people, 8.00%
Escherichia Test Positive: 4 people, 8.00%
Weight Decreased: 3 people, 6.00%
Infection: 3 people, 6.00%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 8.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 6.00%
Diabetes: 2 people, 4.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.00%
Pain: 1 person, 2.00%
High Blood Cholesterol: 1 person, 2.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 2.00%
Depression: 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Stelara and have Cholecystitis infective?

- Check whether Cholecystitis infective is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stelara:

Stelara (96,053 reports)

Browse all side effects of Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis infective:

Cholecystitis infective (392 drugs)

Browse all the conditions that are associated with Cholecystitis infective:

Cholecystitis infective (405 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ustekinumab (the active ingredients of Stelara) and Stelara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.